





































Electroconvulsive Therapy in Depression
Improvement in Quality of Life Depending on Age and Sex
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Objectives: It is uncertain if there are variations in the improvement of
quality in life between sexes and age groups after electroconvulsive therapy
(ECT). The aim of this study was to investigate how health-related quality
of life changed after treatment and to examine differences in the results be-
tween sex and age groups.
Methods: This register-based study used data from the Swedish national
quality register for ECT. The study population was patients diagnosed with
depression who had received ECT. Health-related quality of life was
quantified using the 3-level version the EuroQol 5-dimensional questionnaire
(EQ-5D 3 L). Analysis of variance was used to compare change in EQ-5D
score from pretreatment to posttreatment between sex and age groups.
Results: There was a statistically significant improvement in EQ-5D in-
dex score and EQ visual analog scale (VAS) score in all patient groups after
ECT. The mean improvement in EQ-5D index score and EQ-VAS score
ranged from 0.31 to 0.46 and 28.29 to 39.79, respectively. Elderly patients
had greater improvement in EQ-5D index score and EQ-VAS score than
younger patients. There was no significant difference in improvement be-
tween the sexes. The mean improvement in EQ-5D index score was 0.40
for male patients and 0.41 for female patients.
Conclusions: Electroconvulsive therapy had a considerable effect on
health-related quality of life in patients with depression of both sexes and
all age groups. The improvement was greatest in elderly patients, whomore
often had psychotic features. More studies are needed to investigate the
long-term effects of ECT and to further explain the varying treatment re-
sults between elderly and younger patients.
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D epression is a major health problem. It is associated with in-creased mortality risk and is a major cause of inability to
work.1 Electroconvulsive therapy (ECT) is used in severe depres-
sion with suicidal ideation or psychotic symptoms.2 Electrocon-
vulsive therapy is an effective treatment, with the remission rates
after ECToften reported to exceed 50% for patients with depressive
disorder.3 According to the World Health Organization, quality of
life is a state of physical, mental, and social well-being and not
merely the absence of disease.4 Major depressive disorder has a
large impact on quality of life.5 Patients with major depressive dis-
order report poorer health-related quality of life (HRQoL) than
patientswith other commonmedical conditions, such as hyperten-
sion, arthritis, and angina. Health-related quality of life is espe-
cially low in depressed patients who are referred for ECT.6
The majority of patients with depression who receive ECT
report improvement in HRQoL.7 Improvements in HRQoL tend
to be greater in ECT recipients than in hospitalized depressed pa-
tients treated only with antidepressants.8 There is heterogeneity re-
garding the influence of age on treatment results following ECT
for depression. Some studies report clinically relevant better re-
sults among elderly patients as compared with younger ones,
whereas other studies dispute the relevance of age as a predictor
for efficacy of ECT.9–12 More studies are needed to determine
the effect of age on HRQoL after ECT in treatment of depression.
The EuroQol 5-dimensional questionnaire (EQ-5D) is a stan-
dardized and widely used instrument for measuring health status
and is one of the most common instruments used to quantify
HRQoL.13,14 To our knowledge, EQ-5D has not been used to
quantify HRQoL after treatment of patients with depressive disor-
der with ECT in previous studies. Therefore, the aim of this study
was to investigate how HRQoL, as measured by EQ-5D, of pa-
tients with depressive disorders changed after treatment with
ECT and to examine differences in the treatment results between
sexes and age groups.
MATERIALS AND METHODS
Study Design
The study was a register-based cohort study based on data
from the Swedish National Quality Register for ECT (Q-ECT).
The Q-ECTwas created in 2008, and since 2012 it has included
all hospitals in Sweden that use ECT.2 The register contains detailed
information about patient characteristics, including indications for
therapy and rating on EQ-5D. It is a nonmandatory register, and
the coverage rate is approximately 90%.15
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Outcome Measure
Health-related quality of life was estimated using the 3-level
version of EQ-5D (EQ-5D-3 L). The instrument is designed as a
questionnaire and embodies 2 components: a descriptive system that
consists of 5 questions regarding the patient's health and a rating
of the health state using a visual analog scale (EQ-VAS). The 5
questions in the descriptive system represent different dimensions
of HRQoL: mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression. The patients describe their health status
by selecting 1 of 3 response levels for each question: none, moderate,
or severe problems (scored 1, 2, and 3, respectively).16
To calculate an overall index value based on the 5 questions,
a value set from United Kingdom was used to score the responses
of each patient. This value set operates on a scale between a min-
imum value of −0.59 (for health state 33333) and a maximum
value 1 (for health state 11111).17 On the EQ-VAS, the patients
rate their health status between 0 (worst imaginable state of
health) and 100 (best imaginable state of health).16 The patients
were asked to evaluate their HRQoLwithin aweek before the first
ECT session and within a week after the last ECT session.
The Clinical Global Impression–Improvement (CGI-I) scale
was performed within aweek after the last ECT session. This scale
ranges from 1 to 7 (very much improved, much improved, minimally
improved, not improved, minimally worse, much worse, and very
much worse). A CGI-I score of 1 or 2 was considered improved,
and a CGI-I score of 3 or greater was considered not improved.12
Subjects
The patients included in the study had to fulfill the following
criteria: (1) diagnosed with a depressive episode or major recur-
rent depressive disorder, F32 or F33 in theWorld Health Organiza-
tion International Classification of Diseases, 10th Revision18; (2)
received index ECT in Sweden between 2014 and 2016; and (3)
have available data for EQ-5D index score and EQ-VAS score
in the Q-ECT. The patients were divided into 4 age groups: 15
to 39, 40 to 60, 61 to 80, and 81 to 99 years based on age at the
time of treatment.
Statistical Methods
Cohen d effect sizes were calculated to evaluate the magnitude
of change in EQ-5D index score after ECT in male and female pa-
tients and in the 4 age groups. Paired t tests were used to compare
HRQoL before and after ECT as measured using the EQ-5D index
score and EQ-VAS score in the 4 age groups and in both sexes.
Analysis of variance was used to compare the change in EQ-5D in-
dex score and EQ-VAS score from pre- to post-ECT between the
sexes and among the 4 age groups. SPSS version 22 (SPSS Inc,
Chicago, Ill) was used for all statistical analyses. Aχ2 test was used
to compare the proportion of patients reporting no anxiety or de-
pression after ECT according to EQ-5D between the youngest age
group and the other age groups.McNemar test was used to compare
the proportion of patients reporting extreme anxiety or depression
before ECT and after ECT.
Ethical Considerations
This study is part of the research project Outcome of Treat-
ment for Affective Disorders, which has been approved by the Re-
gional Ethical Vetting Board in Uppsala (2014-174). All patients
in the register have been informed of the register and that their data
could be used for research. The individuals may ask to have their
information removed from the register whenever they want. All
data have been anonymized in this study.
TABLE 1. Characteristics of Study Population (n = 1066)
Characteristic Patients
Age Group, y
15–39 40–60 61–80 81–99
Total 1066 (100.0) 283 (26.5) 323 (30.3) 386 (36.2) 74 (6.9)
Sex
Female 642 (60.0) 173 (61.1) 169 (52.3) 251 (65.0) 49 (66.2)
Male 424 (40.0) 110 (38.9) 154 (47.7) 135 (35.0) 25 (33.8)
No. ECT treatments 7.8 ± 3.0 8.1 ± 3.3 7.9 ± 3.2 7.8 ± 2.8 6.7 ± 2.0
Electrode placement
Unilateral 986 (92.5) 266 (94.0) 293 (90.7) 357 (92.5) 70 (94.6)
Bitemporal 64 (6.0) 14 (4.9) 22 (6.8) 24 (6.2) 4 (5.4)
Bifrontal 7 (0.7) 1 (0.4) 4 (1.2) 2 (0.5) 0 (0.0)
Other 1 (0.1) 0 (0.0) 0 (0.0) 1 (0.3) 0 (0.0)
Information missing 8 (0.8) 2 (0.7) 4 (1.2) 2 (0.5) 0 (0.0)
Anxiety disorder
Yes 358 (33.6) 107 (37.8) 107 (33.1) 120 (31.1) 24 (32.4)
No 708 (66.4) 176 (62.2) 216 (66.9) 266 (68.9) 50 (67.6)
Depression with psychotic features
Yes 204 (19.1) 28 (9.9) 58 (18.0) 95 (24.6) 23 (31.1)
No 862 (80.9) 255 (90.1) 265 (82.0) 291 (75.4) 51 (68.9)
Responder
Yes 795 (74.6) 176 (62.2) 232 (71.8) 327 (84.7) 60 (81.1)
No 192 (18.0) 88 (31.1) 56 (17.3) 41 (10.6) 7 (9.5)
Information missing 79 (7.4) 19 (6.7) 35 (10.8) 18 (4.7) 7 (9.5)
All values are n (%) or mean ± SD.
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RESULTS
Study Population
The study population comprised 1066 patients who fulfilled
all criteria to participate in the study. Patient characteristics are
provided in Table 1. The age of the patients ranged from 15 to
99 years, and the female-to-male ratio was 3:2. The mean number
of ECT treatments was 7.83 for the whole study population. Of
1059 patients, 772 (72.4%) received treatment with pulse width
0.05 millisecond, 103 (9.7%) with pulse width greater than
0.5 millisecond, and 108 (17.3%) with pulse width less than
0.5 millisecond. The most common electrode placement during
ECT was unilateral placement throughout the treatment series,
but 57 patients (5.8%) who received unilateral treatment in the
first ECT session were switched to bitemporal treatment in subse-
quent sessions. A minority of the patients had comorbid anxiety
disorder and/or psychotic features. Of 987 patients, 972 (80.5%)
responded to ECT.
HRQoL Before and After ECT
Health-related quality of life improved in both male and fe-
male patients and in all age groups after ECT. There were statisti-
cally significant improvements in EQ-5D index scores and
EQ-VAS scores after ECT in all patient groups (Table 2). The mean
improvement in EQ-5D index score and EQ-VAS score ranged
from 0.31 to 0.46 and 28.29 to 39.79, respectively (Table 3). There
was no significant difference between male and female patients in
the mean improvement in EQ-5D index score or EQ-VAS score af-
ter ECT (Table 3). However, there was a statistically significant dif-
ference between age groups. The 2 oldest age groups had greater
improvement in EQ-5D index score, as well as in EQ-VAS score,
after ECT than the younger patients (Table 3).
The effect size of change in EQ-5D index score was large for
male and female patients, and Cohen d's were 1.43 and 1.55, re-
spectively. Large effect sizes were shown in all age groups, and
the effect size increased with older age; for age groups 15 to 39,
40 to 60, 61 to 80, and 81 to 99 years, Cohen d's were 1.13,
1.46, 1.58, and 1.61, respectively.
Details of responses on each item of the EQ-5D in each of the
4 age groups separated by sex are presented in Supplementary
Table 1 (Supplemental Digital Content 1, http://links.lww.com/
JECT/A99) and Supplementary Table 2 (Supplemental Digital
Content 2, http://links.lww.com/JECT/A100). There was an
improvement in the ability to perform usual activities and self-
care in all age groups. Before ECT, elderly patients reported more
problems with mobility than did younger patients. After ECT,
elderly patients reported a larger improvement in mobility than
did younger patients.
After ECT, the proportion of patients reporting no anxiety or
depression according to the EQ-5Dwas lowest in the youngest age
group (P < 0.001; Supplementary Table 1, Supplemental Digital
Content 1, http://links.lww.com/JECT/A99; and Supplementary
Table 2, Supplemental Digital Content 2, http://links.lww.com/
JECT/A100). In all age groups, the proportion of patients
reporting extreme anxiety or depression was lower after ECT than
before ECT (Supplementary Table 1, Supplemental Digital
Content 1, http://links.lww.com/JECT/A99; and Supplementary
Table 2, Supplemental Digital Content 2, http://links.lww.com/
JECT/A100; P < 0.001). However, more than half of all patients
still reported “some symptoms” of depression or anxiety after
ECT according to the EQ-5D.
DISCUSSION
The primary focus of this study was to investigate how self-
rated HRQoL, according to age and sex, changed after treatment
with ECT. The results showed an improvement in HRQoL after
treatment with ECT for male and female patients with depression
in all age groups. There were no significant differences in results
betweenmales and females. These results support ECTas an effective
treatmentmethod for both sexes. However, therewere statistically sig-
nificant differences in treatment results between age groups, as indi-
cated by the EQ-5D index scores as well as EQ-VAS scores, with
greater improvements in elderly patients.
A driver of the difference between age groupswas that problems
with mobility were more common among elderly patients before
ECT and that elderly patients experienced a greater improvement in
mobility after ECT thanyounger patients.Another contributing factor
to the difference between age groups was that severe pretreatment
anxiety and depression were more common in elderly patients.
Our results support previous studies showing a higher effi-
cacy of ECT among elderly patients than younger patients. These
results are in line with Brus et al,19 who also used the Q-ECTand
found an association between older age and higher remission rate
after ECT for depression. In addition, Gálvez et al20 reported a
greater improvement in the HRQoL of elderly patients with de-
pression than in that of younger patients after ECT. The Quality
of Life Enjoyment and Satisfaction Questionnaire–Short Form
was used in the study to measure HRQoL, and a large effect size
of change in total HRQoL was reported (Cohen d = 1.43). More-
over, McCall et al6 reported a significantly greater improvement in
mental health and social functioning after ECT in elderly patients
compared with younger patients.
TABLE 2. EQ-5D Index Score and EQ-VAS Score Before and After Treatment According to Sex and Age Groups (n = 1066)
EQ-5D Index Score EQ-VAS Score
Before ECT After ECT P Before ECT After ECT P
Sex
Male 0.33 ± 0.29 0.73 ± 0.27 <0.01 28.16 ± 19.59 62.67 ± 22.92 <0.01
Female 0.28 ± 0.29 0.70 ± 0.28 <0.01 24.53 ± 19.28 60.12 ± 24.04 <0.01
Age, y
15–39 0.32 ± 0.26 0.63 ± 0.29 <0.01 23.15 ± 16.72 51.80 ± 24.10 <0.01
40–60 0.30 ± 0.28 0.71 ± 0.28 <0.01 26.05 ± 20.27 61.04 ± 22.76 <0.01
61–80 0.30 ± 0.32 0.76 ± 0.26 <0.01 27.22 ± 20.25 67.06 ± 22.77 <0.01
81–99 0.27 ± 0.34 0.72 ± 0.20 <0.01 29.83 ± 20.62 65.93 ± 18.34 <0.01
Values are mean ± SD.
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Age also affects the HRQoL deficit patterns. According to
McCall et al,21 younger patients with depression typically report
relationship problems, whereas older patients report problems in
daily living. Cognitive impairment is an important adverse effect
of ECT and has been described as a major concern for elderly
ECT recipients.21 On the other hand, subjective memory worsening
after ECT is more common in younger patients than in older pa-
tients and is more common among females than males.19 However,
improvements in HRQoL after ECTare explained in previous stud-
ies by a reduction of depressive symptoms, with little or no relation
to cognitive adverse effects.21
The results of our study suggest that elderly patients consid-
ered the positive impact of improvements in mobility and reduction
in depressive symptoms and anxiousness on HRQoL to be more
important than any negative impact on cognitive functioning.
Heijnen et al11 described psychotic features and psychomo-
tor retardation as strong predictors for ECT efficacy in patients
with depression. In the current study, the proportion of patients
who had depression with psychotic features was higher among el-
derly patients than younger patients. Also, the higher proportion
of patients with impaired mobility among the elderly indicates
more catatonic features. This could have contributed to the larger
improvement in HRQoL observed among the elderly. Sjöberg
et al22 described an association between dementia and higher
prevalence of depression. Some of the elderly patients in this study
presumably had comorbid dementia, minimal cognitive impair-
ment, or other comorbid diagnoses.22 It is uncertain how this
might have affected the treatment outcome after ECT.
The strengths of this study include the large, population-
based sample. Limitations include lack of a control group not
treated with ECT for comparison. Health-related quality of life
was only examined immediately following the last ECT ses-
sion, with no follow-up assessments. The most severally ill
patients are likely to more often be unable to complete self-
assessment forms and therefore were not included in the study.
These patients tend to have the most benefit from ECT, and the
effect of ECT could therefore be underestimated. Only a small
minority of patients who were not responsive to treatment with
unilateral ECT were switched to bitemporal ECT. Better out-
comes may have been achieved if bilateral treatment had been
used more regularly.
CONCLUSIONS
The HRQoL of patients with depression improved signifi-
cantly after treatment with ECT for both sexes and all age groups.
The improvement was greatest in elderly patients, who more often
than younger patients had psychotic features. More studies are
needed to investigate the long-term effects of ECT and to further
explain the varying treatment results between elderly and
younger patients.
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